NCT04920422View on ClinicalTrials.gov

RE-SEARCH Study: A Study to Learn How and in Which Amount Regorafenib is Given in Usual Practice to Patients in Spain: a Study Looking Back at Cases That Have Already Happened When the Study Begins.

CompletedOBSERVATIONAL
Enrollment

242

Participants

Timeline

Start Date

July 15, 2021

Primary Completion Date

October 7, 2022

Study Completion Date

October 7, 2022

Conditions
Metastatic Colorectal Cancer
Interventions
OTHER

No intervention

Retrospective analysis using database without any intervention assigned in the study.

Trial Locations (1)

Unknown

Many Locations, Multiple Locations

Sponsors

Lead Sponsor

Bayer
All Listed Sponsors
lead

Bayer

INDUSTRY

NCT04920422 - RE-SEARCH Study: A Study to Learn How and in Which Amount Regorafenib is Given in Usual Practice to Patients in Spain: a Study Looking Back at Cases That Have Already Happened When the Study Begins. | Biotech Hunter | Biotech Hunter